Literature DB >> 12535577

Efflux transporters of the human placenta.

Amber M Young1, Courtni E Allen, Kenneth L Audus.   

Abstract

The use of pharmaceuticals during pregnancy is often a necessity for the health of the mother. Until recently, the placenta was viewed as a passive organ through which molecules are passed indiscriminately between mother and fetus. In reality, the placenta contains a plethora of transporters, some of which appear to be specifically dedicated to removal of xenobiotics and toxic endogenous compounds. Drug efflux transporters such as P-glycoprotein (P-gp), several multidrug resistant associated proteins (MRPs) and breast cancer resistant protein (BCRP) may provide mechanisms that protect the developing fetus. Bile acid transporters may also play a role in exporting compounds back into the maternal compartment. Steroid hormones directly influence the level of expression and function in some of these transporters. Investigating the link between the hormones of pregnancy and these drug efflux transporters is one possible key in developing strategies to deliver drugs to the mother with minimal fetal risk.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12535577     DOI: 10.1016/s0169-409x(02)00174-6

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  25 in total

1.  Kinetics of betamethasone and fetal cardiovascular adverse effects in pregnant sheep after different doses.

Authors:  Matthias Schwab; Turhan Coksaygan; Mahesh N Samtani; William J Jusko; Peter W Nathanielsz
Journal:  Obstet Gynecol       Date:  2006-09       Impact factor: 7.661

Review 2.  Developing novel in vitro methods for the risk assessment of developmental and placental toxicants in the environment.

Authors:  Rebecca C Fry; Jacqueline Bangma; John Szilagyi; Julia E Rager
Journal:  Toxicol Appl Pharmacol       Date:  2019-06-22       Impact factor: 4.219

Review 3.  Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies.

Authors:  Chung-Pu Wu; Anna Maria Calcagno; Suresh V Ambudkar
Journal:  Curr Mol Pharmacol       Date:  2008-06       Impact factor: 3.339

4.  Two different docetaxel resistant MCF-7 sublines exhibited different gene expression pattern.

Authors:  Ozlem Darcansoy Işeri; Meltem Demirel Kars; Ufuk Gündüz
Journal:  Mol Biol Rep       Date:  2011-07-01       Impact factor: 2.316

5.  Differential bidirectional transfer of indinavir in the isolated perfused human placenta.

Authors:  Sreeja Sudhakaran; Hany Ghabrial; Roger L Nation; David C M Kong; Neil M Gude; Peter W Angus; Craig R Rayner
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

Review 6.  Excretion of biliary compounds during intrauterine life.

Authors:  Rocio I R Macias; Jose J G Marin; Maria A Serrano
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 7.  Maternal-fetal transport of hypoglycaemic drugs.

Authors:  Facundo Garcia-Bournissen; Denice S Feig; Gideon Koren
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

8.  Response of the ABCG2 promoter in T47D cells and BeWo cells to sex hormone treatment.

Authors:  Satoru Yasuda; Masaki Kobayashi; Shirou Itagaki; Takeshi Hirano; Ken Iseki
Journal:  Mol Biol Rep       Date:  2008-11-08       Impact factor: 2.316

9.  Free diffusion of steroid hormones across biomembranes: a simplex search with implicit solvent model calculations.

Authors:  Idit Oren; Sarel J Fleishman; Amit Kessel; Nir Ben-Tal
Journal:  Biophys J       Date:  2004-08       Impact factor: 4.033

10.  Functional role of p-glycoprotein and binding protein effect on the placental transfer of lopinavir/ritonavir in the ex vivo human perfusion model.

Authors:  Pierre-Francois Ceccaldi; Laurent Gavard; Laurent Mandelbrot; Elisabeth Rey; Robert Farinotti; Jean-Marc Treluyer; Sophie Gil
Journal:  Obstet Gynecol Int       Date:  2009-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.